GE HealthCare Technologies Inc. (NASDAQ:GEHC) Holdings Decreased by New York State Common Retirement Fund

New York State Common Retirement Fund trimmed its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 8.7% in the fourth quarter, Holdings Channel.com reports. The fund owned 512,292 shares of the company’s stock after selling 48,537 shares during the period. New York State Common Retirement Fund’s holdings in GE HealthCare Technologies were worth $39,610,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. First Command Advisory Services Inc. grew its stake in GE HealthCare Technologies by 36,900.0% during the 3rd quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock worth $25,000 after buying an additional 369 shares during the last quarter. Fortitude Family Office LLC bought a new position in GE HealthCare Technologies during the 4th quarter worth $29,000. Legacy Financial Group LLC bought a new position in GE HealthCare Technologies during the 3rd quarter worth $26,000. Turtle Creek Wealth Advisors LLC bought a new position in GE HealthCare Technologies during the 4th quarter worth $30,000. Finally, OFI Invest Asset Management bought a new position in GE HealthCare Technologies during the 3rd quarter worth $26,000. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Trading Up 0.6 %

GEHC stock opened at $86.72 on Thursday. The business has a fifty day moving average price of $88.91 and a 200 day moving average price of $78.27. GE HealthCare Technologies Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $94.50. The stock has a market capitalization of $39.57 billion, a price-to-earnings ratio of 28.72, a P/E/G ratio of 3.00 and a beta of 0.94. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.05 and a quick ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The business had revenue of $5.20 billion during the quarter, compared to analysts’ expectations of $5.09 billion. During the same period in the previous year, the firm earned $1.31 earnings per share. The firm’s quarterly revenue was up 5.3% compared to the same quarter last year. Analysts expect that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be paid a dividend of $0.03 per share. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.97%.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. Morgan Stanley upped their price objective on GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a research note on Monday, February 12th. UBS Group raised GE HealthCare Technologies from a “sell” rating to a “neutral” rating and increased their price target for the stock from $66.00 to $88.00 in a research note on Monday, February 12th. Evercore ISI increased their price target on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th. Argus upped their target price on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a report on Monday, April 1st. Finally, HSBC assumed coverage on GE HealthCare Technologies in a report on Thursday, February 15th. They set a “buy” rating and a $100.00 target price for the company. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $95.09.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.